RxDoctor Payments DataLook up a doctor →

John Mackey

Physician Assistant · Plainfield, CTNPI 1275609984

Payments from drug & device makers

$18,341in general payments, 2019–2025

Across 1,114 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • GSK$2K
  • Boehringer Ingelheim$1K
  • Novo Nordisk$1K
  • Alkermes, Inc.$755
  • plus $8K from 48 others

What the payments were for

  • Food & beverage$18,05598%
  • Education$2852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie207$3,157
AstraZeneca88$1,875
GSK134$1,790
Boehringer Ingelheim80$1,332
Novo Nordisk80$1,179
Alkermes, Inc.39$755
Bayer39$739
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)66$735
Axsome Therapeutics, Inc.27$470
Amgen30$440
Lilly USA, LLC24$434
Phathom Pharmaceuticals, Inc.37$408
Sanofi-aventis U.S. LLC15$301
Scilex Pharmaceuticals Inc.13$296
Regeneron Healthcare Solutions, Inc.10$292
Vanda Pharmaceuticals Inc.12$290
Pfizer15$274
Teva Pharmaceuticals USA, Inc.12$262
Supernus Pharmaceuticals, Inc.12$247
Corium, LLC21$217
Takeda Pharmaceuticals U.S.A., Inc.10$209
Neurocrine Biosciences, Inc.7$206
Otsuka America Pharmaceutical, Inc.10$188
Corcept Therapeutics9$181
Eisai Inc.15$167
Novartis8$153
Biohaven Pharmaceuticals, Inc.8$136
Xeris Pharmaceuticals, Inc.7$126
Endo Pharmaceuticals Inc.5$116
Nestle Healthcare Nutrition Inc.7$113
Exact Sciences5$111
Lundbeck LLC6$109
Genentech USA, Inc.9$106
Astellas Pharma US Inc1$89
Abbott4$77
Biohaven Pharmaceutical Holding Company Ltd.4$72
Amarin Pharma, Inc.4$70
Ardelyx, Inc.3$66
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$64
Merck4$62
Arbor Pharmaceuticals, Inc.4$61
Impel Pharmaceuticals Inc.3$52
Sunovion Pharmaceuticals Inc.2$48
Almatica Pharma LLC2$46
Mylan Specialty L.p.2$37
ANI Pharmaceuticals, Inc.2$33
Ferring Pharmaceuticals Inc.1$25
Jazz Pharmaceuticals Inc.1$25
Paratek Pharmaceuticals, Inc.1$20
Hologic Sales And Service, LLC1$19
Currax Pharmaceuticals LLC1$17
Avanir Pharmaceuticals, Inc.1$17
Idorsia Pharmaceuticals US Inc1$17
Johnson & Johnson1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,341 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.

See all physician assistant providers in Connecticut

Medicare billing

Part B allowed, 2024
$27,182
Medicare patients
159
Services billed
285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide104$135,442
JardianceEmpagliflozin79$86,820
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$64,628
EliquisApixaban42$49,888
RexultiBrexpiprazole17$39,307
JanuviaSitagliptin Phosphate19$28,159
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$22,843
FarxigaDapagliflozin Propanediol12$18,204
TrulicityDulaglutide11$18,041
MyrbetriqMirabegron11$10,516
Aripiprazole15$8,189
Albuterol Sulfate HfaAlbuterol Sulfate98$3,215
Valsartan180$2,646
Atorvastatin Calcium277$2,425
Gabapentin55$2,382

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,179$135,442104 claims
Boehringer IngelheimJardiance$1,332$86,82079 claims
GSKTrelegy Ellipta$1,790$64,62855 claims
PfizerEliquis$274$49,88842 claims
AstraZenecaBreztri Aerosphere, Farxiga$1,875$41,04742 claims
Otsuka America Pharmaceutical, Inc.Rexulti$188$39,30717 claims
MerckJanuvia$62$28,15919 claims
Lilly USA, LLCTrulicity$434$18,04111 claims
Astellas Pharma US IncMyrbetriq$89$10,51611 claims
ANI Pharmaceuticals, Inc.Valsartan$33$2,646180 claims
Almatica Pharma LLCSertraline Hcl$46$37749 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,795 physician assistant providers in Connecticut.

Other physician assistant in Plainfield

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →